Minireview: Glucocorticoids in Autoimmunity: Unexpected Targets and Mechanisms
- 1 July 2011
- journal article
- review article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 25 (7), 1075-1086
- https://doi.org/10.1210/me.2011-0068
Abstract
For decades, natural and synthetic glucocorticoids (GC) have been among the most commonly prescribed classes of immunomodulatory drugs. Their unsurpassed immunosuppressive and antiinflammatory activity along with cost-effectiveness makes these compounds a treatment of choice for the majority of autoimmune and inflammatory diseases, despite serious side effects that frequently accompany GC therapy. The activated GC receptor (GR) that conveys the signaling information of these steroid ligands to the transcriptional machinery engages a number of pathways to ultimately suppress autoimmune responses. Of those, GR-mediated apoptosis of numerous cell types of hematopoietic origin and suppression of proinflammatory cytokine gene expression have been described as the primary mechanisms responsible for the antiinflammatory actions of GC. However, along with the ever-increasing appreciation of the complex functions of the immune system in health and disease, we are beginning to recognize new facets of GR actions in immune cells. Here, we give a brief overview of the extensive literature on the antiinflammatory activities of GC and discuss in greater detail the unexpected pathways, factors, and mechanisms that have recently begun to emerge as novel targets for GC-mediated immunosuppression.Keywords
This publication has 121 references indexed in Scilit:
- TLR recognition of self nucleic acids hampers glucocorticoid activity in lupusNature, 2010
- Th1 and Th17 cellsAnnals of the New York Academy of Sciences, 2010
- IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?Immunological Reviews, 2009
- IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone miceClinical Immunology, 2009
- IRF-4-Binding Protein Inhibits Interleukin-17 and Interleukin-21 Production by Controlling the Activity of IRF-4 Transcription FactorImmunity, 2008
- Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's DiseaseScience, 2008
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryThe Journal of Experimental Medicine, 2008
- Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1The Journal of Experimental Medicine, 2006
- Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypesMolecular Immunology, 2005